Their new not dumb. I think the new reviewers are caught up with Radiogel data and findings and can piece rest of reports coming in pretty easy. Besides, the other 50% are seasoned reviewers and can be of guidance if needed.
- Real progress this entire time he's been "radio silent" with you (You were wrong) - There's been interactions between MK and FDA (You were wrong) - Still progressing and ever closer to IDE submission (You were wrong)